PHT5341C - Cardiac Muscle Dysfunction: Hypertensive Heart Disease, Cardiomyopathies, and Valvular Dysfunction

PHT5341C - Hypertensive Heart Disease, Cardiomyopathies, and Valvular Dysfunction Notes

Introduction to Cardiac Muscle Dysfunction

  • Recap of Prior Units:

    • Atherosclerosis: Leads to stable conditions like chronic angina and Peripheral Artery Disease (PAD), or progresses to myocardial infarction (MI) causing direct myocardial damage and impaired cardiac function.

    • Arrhythmias: Regardless of cause, severe arrhythmias can impair cardiac output.

  • Focus of Current Lecture: This lecture focuses on three additional, common causes of cardiac muscle dysfunction that contribute significantly to heart failure:

    • Hypertensive Heart Disease

    • Cardiomyopathies

    • Valvular Disease

Long-Term Effects of Hypertension on the Cardiac System (Hypertensive Heart Disease)

  • Core Concept: Chronic hypertension forces the left ventricle (LV) to work against elevated vascular resistance.

    • This creates a continuous afterload challenge.

  • Adaptive Response: Left Ventricular Hypertrophy (LVH):

    • The LV wall thickens as an adaptive response to increased stress.

  • Costs of LVH: While initially adaptive, these changes eventually lead to detrimental effects:

    • Myocardial Stiffening and Reduced Compliance: Over time, the thickened myocardium becomes stiffer and less compliant.

    • Diastolic Dysfunction: This reduces the heart's ability to expand during diastole, causing the ventricle to struggle to relax and fill with blood.

    • Reduced Preload: The loss of compliance results in a reduction of preload.

  • Review of Preload and the Frank-Starling Mechanism:

    • Preload: Reflects the volume of blood in the ventricles at the end of diastole, stretching myocardial fibers.

    • Frank-Starling Mechanism: Enhances stroke volume by increasing the force of contraction as preload increases.

    • Impact of Impaired Preload: Impairments in preload, especially during exertion, significantly decrease cardiac output and exercise capacity.

  • Reduced Coronary Reserve:

    • LVH-associated myocardial stiffening reduces coronary reserve, which is the heart's ability to increase blood flow during heightened oxygen demand (e.g., activity).

    • This reduction is due to increased myocardial mass and microvascular dysfunction, leading to a higher risk of myocardial ischemia.

  • Associated Complications: LVH can contribute to:

    • Angina.

    • Increased risk of atrial fibrillation (due to left atrial remodeling).

    • Ventricular arrhythmias (in more advanced cases or with underlying cardiac disease).

  • Progression: The condition can progress from a normal heart to LVH and, in some cases, to decompensated heart failure, where complications are more pronounced.

Valvular Dysfunction

  • Role of Valves: Healthy valves direct blood flow through the heart by opening and closing in response to pressure changes.

  • Impact of Dysfunction: Compromised valve function significantly challenges cardiac output.

  • Types of Valvular Dysfunction:

    • Stenosis:

      • Definition: Narrowing of a valve opening, restricting blood flow.

      • Mechanism: Creates increased resistance to forward blood movement through the affected valve.

      • Cardiac Response: The heart must generate higher pressures to overcome this restriction, increasing the workload on the affected chamber. This leads to hypertrophy or other compensatory changes over time, similar to chronic hypertension.

      • Outcome: If unmanaged, can lead to diastolic dysfunction.

    • Regurgitation (Insufficiency):

      • Definition: A valve fails to close properly, allowing blood to flow backward into the previous chamber.

      • Mechanism: This backflow increases the volume the preceding chamber must handle, causing it to stretch (like overfilling a balloon).

      • Cardiac Response: The added strain on the chamber leads to dilation and weakening of its walls over time.

      • Outcome: Impairs the chamber's ability to pump effectively during systole.

    • Valvular Prolapse:

      • Definition: Valve leaflets bulge back into the prior chamber during contraction, preventing proper closure.

      • Commonality: Most commonly seen with the mitral valve.

      • Outcome: Often leads to regurgitation.

  • Overall Impact: Valvular dysfunction causes structural changes in the heart that impair both systolic and diastolic function, contributing to overall cardiac dysfunction.

  • Clinical Presentation: Valvular diseases can present acutely or chronically.

    • Acute Valvular Dysfunction:

      • Severity: Can be a medical emergency if it causes sudden, severe impairment in cardiac output and hemodynamic stability.

      • Causes: Infective endocarditis (damages valve leaflets or chordae tendineae), myocardial infarction (leading to acute mitral valve regurgitation due to papillary muscle rupture).

      • Symptoms: Severe dyspnea, chest pain, hypotension, or cardiogenic shock.

      • Management: Often requires immediate surgical intervention to repair or replace the valve and stabilize cardiac output.

    • Chronic Valvular Diseases:

      • Development: Develop gradually from congenital anomalies or degenerative processes (e.g., calcification from atherosclerosis).

      • Compensation: The heart initially compensates, delaying symptom onset.

      • Example (Chronic Aortic Stenosis): Leads to progressive left ventricular hypertrophy, maintaining cardiac output until compensatory mechanisms fail.

      • Symptoms: Exertional dyspnea, fatigue, and angina emerge gradually.

      • Management: Focuses on regular monitoring, symptom control, and planned surgical intervention before irreversible damage occurs.

  • Role of Physical Therapists (PTs) in Valvular Disease Management:

    • Acute Dysfunction: PTs must understand that acute dysfunction causes rapid hemodynamic instability, requiring immediate medical attention and impacting exercise safety.

    • Chronic Disease: PTs need to recognize compensatory mechanisms and monitor for decompensation. This is key to tailoring interventions and ensuring timely referral.

  • Diagnostic Assessment: Plays a crucial role in determining the timing and type of intervention.

    • Echocardiography (First Choice):

      • Transthoracic Echocardiography: Provides key details on valve anatomy, function, and blood flow, identifying stenosis or regurgitation.

      • Transesophageal Echocardiography: Offers enhanced visualization when transthoracic results are inconclusive, especially useful for evaluating mitral valves, prosthetic valves, and endocarditis.

      • Stress Echocardiography: Evaluates valve function under physical or pharmacological stress to assess the impact of valvular lesions on exercise capacity.

    • Cardiac Catheterization: Valuable for assessing stenosis or regurgitation severity and for pre-surgical evaluation, particularly if coronary artery disease is suspected.

    • Complementary Tools: ECG and chest X-rays provide insight into cardiac and pulmonary function, enabling early detection and intervention.

  • Management Strategies: Tailored to the type of dysfunction and patient's clinical condition, including medical therapy, interventional procedures, and surgical techniques.

    • Surgical Interventions (Often Definitive for Severe Disease):

      • Valve Repair (Preferred): Preserves native valve structure and supports normal heart function.

        • Techniques:

          • Annuloplasty: Reinforces the valve's annulus to restore proper closure.

          • Chordal Procedures: Repair torn or prolapsed segments.

          • Valvulotomy: Involves making incisions to relieve narrowing and improve blood flow, used for conditions like congenital valve stenosis.

      • Valve Replacement (Necessary for Severely Damaged Valves):

        • Mechanical Valves: Highly durable, but require lifelong anticoagulation therapy.

        • Bioprosthetic Valves: Eliminate the need for long-term anticoagulation, but have a shorter functional lifespan.

      • Decision Factors: The choice between repair and replacement, and between surgical and percutaneous interventions, depends on the affected valve, dysfunction nature, patient's age (>$ 65yearsforbioprostheticsusually),comorbidities,andoverallriskprofile.</p></li></ul></li><li><p><strong>LessInvasiveOptions:</strong></p><ul><li><p><strong>TranscatheterAorticValveReplacements(TAVR):</strong></p><ul><li><p><strong>Procedure:</strong>Catheter−basedproceduredeliveringacollapsiblebioprostheticvalvethroughthefemoralartery(oralternativeaccesspoint)andexpandingitwithinthediseasedaorticvalve.</p></li><li><p><strong>Preference:</strong>Preferredforpatientsathighorprohibitivesurgicalrisk(duetoadvancedage,frailty,orsignificantcomorbidities)asitavoidsopen−heartsurgery.</p></li></ul></li><li><p><strong>BalloonValvuloplasty:</strong></p><ul><li><p><strong>Purpose:</strong>Typicallyusedasatemporarymeasuretorelievestenosisinhigh−riskpatientsorasabridgetomoredefinitiveinterventions.</p></li><li><p><strong>StandaloneUse:</strong>Insomecongenitalcases,itmayserveasastandalonetreatment.</p></li></ul></li></ul></li><li><p><strong>FutureDirections:</strong>Advancesinminimallyinvasivetechniquesandregenerativemedicineareshapingthefutureofvalvulardiseasemanagement,offeringimprovedoutcomes.</p></li></ul></li></ul><h4id="cd2ae053−1045−4312−b22a−18f22a0a8eec"data−toc−id="cd2ae053−1045−4312−b22a−18f22a0a8eec"collapsed="false"seolevelmigrated="true">RehabilitationConsiderationsFollowingValvularSurgery</h4><ul><li><p><strong>AcuteRecoveryPhase(PTs′Role):</strong>PTsmustintegratesurgicalconsiderations,hemodynamicchanges,andpostoperativecareintotreatmentstrategiesforsafeandeffectiverehabilitation.</p></li><li><p><strong>MinimallyInvasiveProcedures(e.g.,TAVRs):</strong></p><ul><li><p>Typicallyresultinlesspainandfasterrecovery,allowingforearlieractivityprogression.</p></li><li><p><strong>PatientProfile:</strong>However,TAVRpatientsoftenhavesignificantcomorbidities(e.g.,pre−existingfrailty,deconditioning,mobilitydeficits)thatmightimpactexercisetolerance.</p></li></ul></li><li><p><strong>KeyMonitoringandManagementPointsforPTs:</strong></p><ul><li><p><strong>EarlyMobilization:</strong>Generallyencouraged.</p></li><li><p><strong>ComplicationMonitoring:</strong>PTsmustmonitorforcomplicationssuchasarrhythmias(commonaftervalveprocedures)orvascularaccessissues.</p></li><li><p><strong>HemodynamicStability:</strong>Essentialtoassessatrestandwithactivity,withpromptattentiontosignsofinstability(e.g.,dyspnea,fatigue).</p></li><li><p><strong>ValvularRepairsvs.Replacements:</strong>Valvularrepairs,whichpreservenativetissueandgenerallyhavebetterlong−termoutcomes,mayallowforquickerfunctionalprogressionthanreplacements.</p></li><li><p><strong>AnticoagulationManagement:</strong>Forpatientsonlong−termanticoagulation,bleedingrisksmustbecarefullymanaged.</p><ul><li><p>PTsplayakeyroleineducatingpatientsonanticoagulationprotocolsandrecognizingsignsofbleeding.</p></li></ul></li><li><p><strong>IncisionSiteInspection:</strong>Regularinspectionofincisionsitesforinfectionordehiscenceiscriticaltopreventcomplications.</p></li></ul></li><li><p><strong>OverallGoalforPTs:</strong>Byaddressingthesefactors,PTscanfacilitatesaferrecoveriesandimprovefunctionaloutcomesfollowingvalvularsurgery.</p></li></ul><h4id="1f226c6d−833c−4b8b−bc31−90bb8bb11aa4"data−toc−id="1f226c6d−833c−4b8b−bc31−90bb8bb11aa4"collapsed="false"seolevelmigrated="true">Cardiomyopathies</h4><ul><li><p><strong>Definition:</strong>Agroupofdiseasesinvolvingstructuralandfunctionalabnormalitiesintheheartmuscle.</p></li><li><p><strong>DistinguishingFeature:</strong>Cardiomyopathiesare<em>not</em>primarilycausedbycommonfactorslikecoronaryarterydisease,hypertension,valvulardisease,orcongenitalheartdefects(factorstraditionallylinkedtoheartdysfunction).</p></li><li><p><strong>Origin:</strong>Instead,theyarisefromintrinsicabnormalitieswithinthemyocardiumitself.</p></li><li><p><strong>Consequences:</strong>Theseissuesimpaircardiacfunctionandcanleadtosystolicordiastolicdysfunction,manifestingasheartfailure,arrhythmias,orevensuddencardiacdeath.</p></li><li><p><strong>ThreePrimaryTypesofCardiomyopathies:</strong></p><ul><li><p><strong>DilatedCardiomyopathy(DCM):</strong></p><ul><li><p><strong>Characteristics:</strong>Enlargementoftheventricles.</p></li><li><p><strong>Impact:</strong>Resultsinweakenedcontractionandreducedcardiacoutput.</p></li></ul></li><li><p><strong>HypertrophicCardiomyopathy(HCM):</strong></p><ul><li><p><strong>Characteristics:</strong>Inappropriatethickeningoftheventricularwalls.</p></li><li><p><strong>Distinction:</strong>Unlikehypertrophycausedbyincreasedworkloadsorpressures(e.g.,hypertension),thisthickeningisoftenduetogeneticmutations.</p></li></ul></li><li><p><strong>RestrictiveCardiomyopathy:</strong></p><ul><li><p><strong>Characteristics:</strong>Stiffenedventricularwalls.</p></li><li><p><strong>Impact:</strong>Limitsdiastolicfilling,leadingtoreducedcardiacoutputdespitepreservedcontractilefunction.</p></li></ul></li></ul></li><li><p><strong>CategorizationbyCause:</strong>Canalsobecategorizedasgenetic,acquired,ormixed,withmanypatientsexhibitingoverlappingfeatures.</p></li><li><p><strong>DiagnosticTools:</strong>Echocardiographyandmyocardialbiopsyplayacriticalroleindifferentiatingthesetypesandguidingappropriatetreatment.</p></li><li><p><strong>DetailedFocusonDCMandHCM:</strong></p><ul><li><p>∗∗DilatedCardiomyopathy(DCM):</p><ul><li><p><strong>Mechanism:</strong>Characterizedbyinefficientheartcontractions,oftenduetomitochondrialdysfunctionimpairingenergyproduction.</p></li><li><p><strong>CompensationthenDeterioration:</strong>Tocompensate,theleftventricledilatestoincreasepreload,allowingittoholdmorebloodattheendofdiastole.Initially,thisstretchingenhancescontractionviatheFrank−Starlingmechanism.However,overtime,excessivestretchingweakensthemuscle,leadingtosystolicdysfunctionandreducedejectionofblood.</p></li><li><p><strong>PediatricSignificance:</strong>years for bioprosthetics usually), comorbidities, and overall risk profile.</p></li></ul></li><li><p><strong>Less Invasive Options:</strong></p><ul><li><p><strong>Transcatheter Aortic Valve Replacements (TAVR):</strong></p><ul><li><p><strong>Procedure:</strong> Catheter-based procedure delivering a collapsible bioprosthetic valve through the femoral artery (or alternative access point) and expanding it within the diseased aortic valve.</p></li><li><p><strong>Preference:</strong> Preferred for patients at high or prohibitive surgical risk (due to advanced age, frailty, or significant comorbidities) as it avoids open-heart surgery.</p></li></ul></li><li><p><strong>Balloon Valvuloplasty:</strong></p><ul><li><p><strong>Purpose:</strong> Typically used as a temporary measure to relieve stenosis in high-risk patients or as a bridge to more definitive interventions.</p></li><li><p><strong>Standalone Use:</strong> In some congenital cases, it may serve as a standalone treatment.</p></li></ul></li></ul></li><li><p><strong>Future Directions:</strong> Advances in minimally invasive techniques and regenerative medicine are shaping the future of valvular disease management, offering improved outcomes.</p></li></ul></li></ul><h4 id="cd2ae053-1045-4312-b22a-18f22a0a8eec" data-toc-id="cd2ae053-1045-4312-b22a-18f22a0a8eec" collapsed="false" seolevelmigrated="true">Rehabilitation Considerations Following Valvular Surgery</h4><ul><li><p><strong>Acute Recovery Phase (PTs' Role):</strong> PTs must integrate surgical considerations, hemodynamic changes, and postoperative care into treatment strategies for safe and effective rehabilitation.</p></li><li><p><strong>Minimally Invasive Procedures (e.g., TAVRs):</strong></p><ul><li><p>Typically result in less pain and faster recovery, allowing for earlier activity progression.</p></li><li><p><strong>Patient Profile:</strong> However, TAVR patients often have significant comorbidities (e.g., pre-existing frailty, deconditioning, mobility deficits) that might impact exercise tolerance.</p></li></ul></li><li><p><strong>Key Monitoring and Management Points for PTs:</strong></p><ul><li><p><strong>Early Mobilization:</strong> Generally encouraged.</p></li><li><p><strong>Complication Monitoring:</strong> PTs must monitor for complications such as arrhythmias (common after valve procedures) or vascular access issues.</p></li><li><p><strong>Hemodynamic Stability:</strong> Essential to assess at rest and with activity, with prompt attention to signs of instability (e.g., dyspnea, fatigue).</p></li><li><p><strong>Valvular Repairs vs. Replacements:</strong> Valvular repairs, which preserve native tissue and generally have better long-term outcomes, may allow for quicker functional progression than replacements.</p></li><li><p><strong>Anticoagulation Management:</strong> For patients on long-term anticoagulation, bleeding risks must be carefully managed.</p><ul><li><p>PTs play a key role in educating patients on anticoagulation protocols and recognizing signs of bleeding.</p></li></ul></li><li><p><strong>Incision Site Inspection:</strong> Regular inspection of incision sites for infection or dehiscence is critical to prevent complications.</p></li></ul></li><li><p><strong>Overall Goal for PTs:</strong> By addressing these factors, PTs can facilitate safer recoveries and improve functional outcomes following valvular surgery.</p></li></ul><h4 id="1f226c6d-833c-4b8b-bc31-90bb8bb11aa4" data-toc-id="1f226c6d-833c-4b8b-bc31-90bb8bb11aa4" collapsed="false" seolevelmigrated="true">Cardiomyopathies</h4><ul><li><p><strong>Definition:</strong> A group of diseases involving structural and functional abnormalities in the heart muscle.</p></li><li><p><strong>Distinguishing Feature:</strong> Cardiomyopathies are <em>not</em> primarily caused by common factors like coronary artery disease, hypertension, valvular disease, or congenital heart defects (factors traditionally linked to heart dysfunction).</p></li><li><p><strong>Origin:</strong> Instead, they arise from intrinsic abnormalities within the myocardium itself.</p></li><li><p><strong>Consequences:</strong> These issues impair cardiac function and can lead to systolic or diastolic dysfunction, manifesting as heart failure, arrhythmias, or even sudden cardiac death.</p></li><li><p><strong>Three Primary Types of Cardiomyopathies:</strong></p><ul><li><p><strong>Dilated Cardiomyopathy (DCM):</strong></p><ul><li><p><strong>Characteristics:</strong> Enlargement of the ventricles.</p></li><li><p><strong>Impact:</strong> Results in weakened contraction and reduced cardiac output.</p></li></ul></li><li><p><strong>Hypertrophic Cardiomyopathy (HCM):</strong></p><ul><li><p><strong>Characteristics:</strong> Inappropriate thickening of the ventricular walls.</p></li><li><p><strong>Distinction:</strong> Unlike hypertrophy caused by increased workloads or pressures (e.g., hypertension), this thickening is often due to genetic mutations.</p></li></ul></li><li><p><strong>Restrictive Cardiomyopathy:</strong></p><ul><li><p><strong>Characteristics:</strong> Stiffened ventricular walls.</p></li><li><p><strong>Impact:</strong> Limits diastolic filling, leading to reduced cardiac output despite preserved contractile function.</p></li></ul></li></ul></li><li><p><strong>Categorization by Cause:</strong> Can also be categorized as genetic, acquired, or mixed, with many patients exhibiting overlapping features.</p></li><li><p><strong>Diagnostic Tools:</strong> Echocardiography and myocardial biopsy play a critical role in differentiating these types and guiding appropriate treatment.</p></li><li><p><strong>Detailed Focus on DCM and HCM:</strong></p><ul><li><p>**Dilated Cardiomyopathy (DCM):</p><ul><li><p><strong>Mechanism:</strong> Characterized by inefficient heart contractions, often due to mitochondrial dysfunction impairing energy production.</p></li><li><p><strong>Compensation then Deterioration:</strong> To compensate, the left ventricle dilates to increase preload, allowing it to hold more blood at the end of diastole. Initially, this stretching enhances contraction via the Frank-Starling mechanism. However, over time, excessive stretching weakens the muscle, leading to systolic dysfunction and reduced ejection of blood.</p></li><li><p><strong>Pediatric Significance:</strong>DCMistheleadingcauseofhearttransplantsinchildrenoveris the leading cause of heart transplants in children over1yearofage.</p></li></ul></li><li><p>∗∗HypertrophicCardiomyopathy(HCM):</p><ul><li><p><strong>Mechanism:</strong>Ageneticdisordercharacterizedbyasymmetricalmyocardialhypertrophyanddisorganizedfibers.</p></li><li><p><strong>Impact:</strong>Thishypercontractileheartstruggleswithdiastolicdysfunction,asthethickenedventricularwallsimpedefillingduringdiastole.</p></li><li><p><strong>Consequences:</strong>Theresultingelevationinenddiastolicpressurecontributestopulmonarycongestionandsymptomslikedyspnea.</p></li><li><p><strong>ClinicalSignificance:</strong>year of age.</p></li></ul></li><li><p>**Hypertrophic Cardiomyopathy (HCM):</p><ul><li><p><strong>Mechanism:</strong> A genetic disorder characterized by asymmetrical myocardial hypertrophy and disorganized fibers.</p></li><li><p><strong>Impact:</strong> This hypercontractile heart struggles with diastolic dysfunction, as the thickened ventricular walls impede filling during diastole.</p></li><li><p><strong>Consequences:</strong> The resulting elevation in end diastolic pressure contributes to pulmonary congestion and symptoms like dyspnea.</p></li><li><p><strong>Clinical Significance:</strong>HCM$$ is the most common identifiable cause of sudden cardiac death in young athletes in the US (e.g., undiagnosed cases in football and basketball players).

  • Shared Concerns in DCM and HCM:

    • Heightened Risk for Arrhythmias:

      • In DCM: The dilated ventricular walls can disrupt electrical conduction, creating instability.

      • In HCM: The disorganized myocardial fibers provide a substrate for arrhythmias.

      • PTs' Role: This risk necessitates vigilant monitoring during physical therapy, and exercise should be adjusted based on the individual patient's risk profile.

    • Exercise-Induced Hypotension:

      • In DCM: Inadequate pumping capacity may cause blood pressure to drop during exertion.

      • In HCM: The hypertrophied heart may fail to maintain adequate cardiac output, leading to hypotension.

      • PTs' Role: Requires careful monitoring and a cautious approach to progressing exercise intensity to prevent sudden drops in blood pressure, which could lead to adverse events.

Conclusion

  • Multiple Etiologies: Cardiac muscle dysfunction can arise from multiple causes, including hypertension, valvular disease, and cardiomyopathies.

  • Distinct Implications: Each condition has distinct implications for cardiac function and rehabilitation.

  • Importance of Pathophysiology: Understanding the pathophysiology behind these conditions is essential for guiding safe and effective interventions, whether monitoring for hemodynamic instability, adjusting exercise prescriptions, or recognizing early signs of decompensation.